BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7970443)

  • 1. Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours in the upper aerodigestive and respiratory tract.
    De Bree R; Roos JC; Quak JJ; Den Hollander W; Snow GB; Van Dongen GA
    Nucl Med Commun; 1994 Aug; 15(8):613-27. PubMed ID: 7970443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
    Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
    Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunodiagnosis of lymph node metastases in head and neck cancer.
    de Bree R; Roos JC; Verel I; van Dongen GA; Snow GB
    Oral Dis; 2003 Sep; 9(5):241-8. PubMed ID: 14628891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
    Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
    Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.
    de Bree R; Roos JC; Quak JJ; den Hollander W; van den Brekel MW; van der Wal JE; Tobi H; Snow GB; van Dongen GA
    J Nucl Med; 1994 May; 35(5):775-83. PubMed ID: 8176458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
    van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
    Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT.
    Baum RP; Adams S; Kiefer J; Niesen A; Knecht R; Howaldt HP; Hertel A; Adamietz IA; Sykes T; Boniface GR
    Acta Oncol; 1993; 32(7-8):747-51. PubMed ID: 8305222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
    Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
    J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
    Quak J; van Dongen G
    Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region.
    Heissler E; Grünert B; Barzen G; Fritsche L; Hell B; Felix R; Bier J
    Int J Oral Maxillofac Surg; 1994 Jun; 23(3):149-52. PubMed ID: 7930767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.
    de Bree R; Kuik DJ; Quak JJ; Roos JC; van den Brekel MW; Castelijns JA; van Wagtendonk FW; Greuter H; Snow GB; van Dongen GA
    Eur J Nucl Med; 1998 Nov; 25(11):1562-5. PubMed ID: 9799354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
    de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
    Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of chest CT-scanning for staging of progressed or recurrent head and neck squamous cell carcinomas (HNSCC)].
    Tesche S; Habermann CR; Sagowski C; Wenzel S; Metternich FU
    Laryngorhinootologie; 2006 Feb; 85(2):93-8. PubMed ID: 16498537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.
    Sandström K; Haylock AK; Spiegelberg D; Qvarnström F; Wester K; Nestor M
    Int J Oncol; 2012 May; 40(5):1525-32. PubMed ID: 22307465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas.
    Quak JJ; Schrijvers HG; Brakkee JG; Davis HD; Scheper RJ; Meijer CJ; Snow GB; Van Dongen GA
    Int J Cancer; 1992 Feb; 50(4):507-13. PubMed ID: 1537614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.